Skip to main content
. 2021 Feb 23;11(2):e324. doi: 10.1002/ctm2.324

FIGURE 7.

FIGURE 7

Our findings illustrate an important role of IL‐22 in controlling kidney cell metabolism to treat kidney damage through activating the STAT3‐AMPK/AKT‐PFKFB3 axis. These results suggest that the therapeutic opportunities of IL‐22 and targeting associated metabolic signaling could be directly favorable for numerous kidney damage treatment or prevention